Predictors of which patients will maintain symptom stability in absence of antipsychotic treatment for schizophrenia

Schizophrenia is a long-term mental health condition that affects how a person thinks, feels, and behaves. People with schizophrenia may hear voices, see things that aren't there, or have strong beliefs that are not based in reality. It affects about 1 in every 300 people worldwide. While antipsychotic medications are commonly used to manage symptoms, not everyone benefits from them, and many people experience unwanted side effects such as weight gain, tiredness, or difficulty thinking clearly. These side effects can make long-term treatment challenging for patients and their doctors. Antipsychotic medications work by interferring with a chemical called dopamine which helps transmit messages between cells in the brain.

Some researchers and clinicians are exploring an alternative approach called "targeted" or "intermittent" treatment. In this approach, antipsychotic medication is given only during times when symptoms return or worsen, and then stopped once the person feels stable again. However, we still do not know which patients can stay well without needing continuous medication. This study aims to find out if there are specific patterns of symptoms, known as predictors, that can help predict who can remain stable without regular antipsychotic treatment.

The goal of this research is to improve treatment decisions by identifying people with schizophrenia who may safely use less medication, reducing the risk of side effects while still keeping their symptoms under control. This could help doctors personalize treatment plans and improve quality of life for patients.

To do this, the study will combine data from six previous clinical trials that tested antipsychotic medications against a placebo (a treatment with no active drug).
Researchers will look at each participant’s symptoms at the start of the study, especially focusing on those who had mostly “negative symptoms” (such as lack of motivation or reduced emotional expression) and low levels of agitation. The study will explore whether people with this symptom pattern are more likely to stay well without ongoing medication.

The main outcomes being studied are how long it takes for a person to experience a return of symptoms (called "relapse"), to stop participating in the study, or to require hospitalization. The research will use a method called "meta-analysis," which allows scientists to combine and analyze data from multiple studies to get stronger, more reliable results.

Ultimately, this research hopes to support better, more personalized care for people living with schizophrenia.